Cyclooxygenase-2 Promotes Hepatocellular Apoptosis by Interacting with TNF-α and IL-6 in the Pathogenesis of Nonalcoholic Steatohepatitis in Rats

被引:47
作者
Cheng, Qi [1 ]
Li, Ning [1 ]
Chen, Mingquan [1 ]
Zheng, Jianming [1 ]
Qian, Zhiping [2 ]
Wang, Xinyu [1 ]
Huang, Chong [1 ]
Xu, Shuchang [3 ]
Shi, Guangfeng [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China
[2] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Intens Care Unit, Shanghai 201508, Peoples R China
[3] Tongji Univ, Tongji Hosp, Dept Gastroenterol, Shanghai 200065, Peoples R China
基金
美国国家科学基金会;
关键词
Nonalcoholic steatohepatitis; COX-2; TNF-alpha; Apoptosis; IL-6; Inflammation; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; FATTY LIVER-DISEASE; GENE-EXPRESSION; RECEPTORS; MIGRATION; CYTOKINES; DEATH; MICE;
D O I
10.1007/s10620-013-2823-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background and Purpose The underlying mechanisms of nonalcoholic steatohepatitis (NASH) are poorly understood, and little is known about hepatocellular apoptosis in NASH. Cyclooxygenase (COX)-2, the key enzyme in eicosanoid metabolism, is highly expressed in NASH. COX-2 can also regulate the release of mediators of inflammation, such as tumor necrosis factor (TNF)-alpha and interleukin (IL)-6. The aim of our study was to evaluate the effects of COX-2 on hepatocellular apoptosis and the mechanism of the action in the pathogenesis of NASH in rats. Methods Sprague-Dawley rats were fed a high-fat diet (HFD) or standard diet for 8 and 12 weeks. COX-2 and cytokines expression in hepatic tissue and TNF-alpha and IL-6 levels in serum were measured at 8 and 12 weeks. Moreover, celecoxib (10 mg/kg body weight once a day) was administered to rats for 4 weeks to inhibit the expression of COX-2. Liver pathology was assessed by hematoxylin and eosin (H&E) stain and electron microscopy. Hepatocyte apoptosis was evaluated by TUNEL staining. Results COX-2 messenger RNA and protein were highly expressed in livers of HFD rats and were correlated with the severity of steatohepatitis (R = 0.82, p < 0.01). COX-2 upregulation was preceded by increases in TNF-a and IL-6. The level of hepatocellular apoptosis was significantly higher in HFD rats than in the control rats. The hepatocellular apoptosis was suppressed by the inhibition of COX-2. Conclusions COX-2 may promote hepatocellular apoptosis by interacting with TNF-alpha and IL-6 in NASH in rats.
引用
收藏
页码:2895 / 2902
页数:8
相关论文
共 27 条
[1]
Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[2]
Brunt EM, 2004, SEMIN LIVER DIS, V24, P3
[3]
Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients [J].
Crespo, J ;
Cayón, A ;
Fernández-Gil, P ;
Hernández-Guerra, M ;
Mayorga, M ;
Domínguez-Díez, A ;
Fernández-Escalante, JC ;
Pons-Romero, F .
HEPATOLOGY, 2001, 34 (06) :1158-1163
[4]
Steatohepatitis: A tale of two "hits"? [J].
Day, CP ;
James, OFW .
GASTROENTEROLOGY, 1998, 114 (04) :842-845
[5]
NF-κB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis [J].
Dela Peña, A ;
Leclercq, I ;
Field, J ;
George, J ;
Jones, B ;
Farrell, G .
GASTROENTEROLOGY, 2005, 129 (05) :1663-1674
[6]
ALCOHOL-LIKE LIVER-DISEASE IN NONALCOHOLICS - A CLINICAL AND HISTOLOGIC COMPARISON WITH ALCOHOL-INDUCED LIVER-INJURY [J].
DIEHL, AM ;
GOODMAN, Z ;
ISHAK, KG .
GASTROENTEROLOGY, 1988, 95 (04) :1056-1062
[7]
Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-κB-independent, caspase-3-dependent pathway [J].
Faouzi, S ;
Burckhardt, BE ;
Hanson, JC ;
Campe, CB ;
Schrum, LW ;
Rippe, RA ;
Maher, JJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) :49077-49082
[8]
Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis [J].
Feldstein, AE ;
Canbay, A ;
Angulo, P ;
Taniai, M ;
Burgart, LJ ;
Lindor, KD ;
Gores, GJ .
GASTROENTEROLOGY, 2003, 125 (02) :437-443
[9]
The role of the macrophage in apoptosis: Hunter, gatherer, and regulator [J].
Geske, FJ ;
Monks, J ;
Lehman, L ;
Fadok, VA .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (01) :16-26
[10]
Cyclooxygenase-5: a target for the prevention and treatment of breast cancer [J].
Howe, LR ;
Subbaramaiah, K ;
Brown, AMC ;
Dannenberg, AJ .
ENDOCRINE-RELATED CANCER, 2001, 8 (02) :97-114